PERINATAL HYPOXIA: ADRENOCORTICAL-METABOLIC ADAPTATIONS
围产期缺氧:肾上腺皮质代谢适应
基本信息
- 批准号:6580136
- 负责人:
- 金额:$ 21.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-01-01 至 2006-12-31
- 项目状态:已结题
- 来源:
- 关键词:adrenocorticotropic hormone arginine vasopressin corticosteroid receptors corticosterone corticotropin releasing factor embryo /fetus hypoxia environmental adaptation enzyme activity glucocorticoids hormone regulation /control mechanism hormone therapy hyperlipidemia hypothalamic pituitary adrenal axis hypoxia neonatorum laboratory rat lipid metabolism metabolomics mineralocorticoids northern blottings perinatal polymerase chain reaction proopiomelanocortin receptor expression steroid biosynthesis stress
项目摘要
DESCRIPTION (provided by applicant): Hypoxia during the perinatal period and during early infancy is a significant cause of mortality and morbidity. Adrenocortical hormones are a vital component of the adaptation to hypoxic stress. Furthermore, neonatal hypoxic hyperlipidemia is a significant clinical entity, and changes in specific lipid metabolites alter adrenal function. The long-term objective of this proposal is to characterize the short and long-term consequences of perinatal hypoxia on the control of the hypothalamic-pituitary-adrenal (HPA) system and lipid metabolism in the rat. Specific Aims 1 and 2 will evaluate the effect of neonatal hypoxia on the control of the hypothalamic-pituitary-adrenal axis by evaluating intracellular and systemic controllers of steroidogenesis, the timing and mechanisms of the stress-hyporesponsive period (SHRP), and the negative feedback control of CRH and POMC expression and ACTH release. Specific Aim 3 will characterize the long-term sequellae of perinatal hypoxia by evaluating subsequent HPA responses to stimuli in the adult rat. Specific Aim 4 will more fully characterize neonatal hypoxic hyperlipidemia by analyzing the interaction of neonatal hypoxia and glucocorticoid therapy, and by performing metabolomic analysis. Neonatal hypoxia from birth is accomplished by exposing newborn rats (with their lactating dams) to a hypoxic environment. Perinatal hypoxia is accomplished by exposing late-gestational pregnant rats to hypoxia and allowing them to deliver in a hypoxic environment. Physiological, biochemical and molecular assessment of adrenocortical function is performed by ACTH injection in vivo, using dispersed cells, evaluating StAR and PBR expression, and measuring CBG and glucocorticoid clearance. Hypothalamic-pituitary function is assessed by measuring stress- and CRH-induced ACTH release, by evaluating feedback sensitivity, and by analyzing pituitary, hypothalamic, and hippocampal function and pertinent receptor/hormone expression. Metabolic function is assessed by analysis of hepatic enzyme activity, as well as complete metabolomic analysis of serum and hepatic lipids. Characterization of the hypothalamic-pituitary-adrenal and metabolic adaptations to perinatal hypoxia can lead to new diagnostic approaches and therapies to minimize morbidity and mortality.
描述(由申请人提供):围产期和婴儿早期缺氧是死亡和发病的重要原因。肾上腺皮质激素是适应缺氧应激的重要组成部分。此外,新生儿缺氧性高脂血症是一个重要的临床实体,特定脂质代谢物的变化改变肾上腺功能。本建议的长期目标是表征围产期缺氧对大鼠下丘脑-垂体-肾上腺(HPA)系统和脂质代谢控制的短期和长期后果。具体目标1和2将通过评价类固醇生成的细胞内和全身控制器、应激低反应期(SHRP)的时间和机制以及CRH和POMC表达和ACTH释放的负反馈控制,评价新生儿缺氧对下丘脑-垂体-肾上腺轴控制的影响。具体目标3将通过评估成年大鼠对刺激的后续HPA反应来表征围产期缺氧的长期后遗症。具体目标4将通过分析新生儿缺氧和糖皮质激素治疗的相互作用以及进行代谢组学分析,更全面地表征新生儿缺氧性高脂血症。通过将新生大鼠(及其哺乳期母鼠)暴露于缺氧环境,实现出生后的新生儿缺氧。围产期缺氧是通过将妊娠晚期的大鼠暴露于缺氧环境中并允许它们在缺氧环境中分娩来实现的。肾上腺皮质功能的生理学、生物化学和分子学评估通过体内ACTH注射进行,使用分散的细胞,评估星星和PBR表达,并测量CBG和糖皮质激素清除率。通过测量应激和CRH诱导的ACTH释放,通过评价反馈敏感性,以及通过分析垂体、下丘脑和海马功能和相关受体/激素表达来评估下丘脑-垂体功能。通过肝酶活性分析以及血清和肝脏脂质的完全代谢组学分析评估代谢功能。下丘脑-垂体-肾上腺和围产期缺氧代谢适应的特征可以带来新的诊断方法和疗法,以最大限度地减少发病率和死亡率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HERSHEL RAFF其他文献
HERSHEL RAFF的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HERSHEL RAFF', 18)}}的其他基金
PERINATAL HYPOXIA--ADRENOCORTICAL/METABOLIC ADAPTATIONS
围产期缺氧——肾上腺皮质/代谢适应
- 批准号:
2724093 - 财政年份:1999
- 资助金额:
$ 21.21万 - 项目类别:
PERINATAL HYPOXIA--ADRENOCORTICAL/METABOLIC ADAPTATIONS
围产期缺氧——肾上腺皮质/代谢适应
- 批准号:
6138085 - 财政年份:1999
- 资助金额:
$ 21.21万 - 项目类别:
PERINATAL HYPOXIA--ADRENOCORTICAL/METABOLIC ADAPTATIONS
围产期缺氧——肾上腺皮质/代谢适应
- 批准号:
6342526 - 财政年份:1999
- 资助金额:
$ 21.21万 - 项目类别:
PERINATAL HYPOXIA: ADRENOCORTICAL-METABOLIC ADAPTATIONS
围产期缺氧:肾上腺皮质代谢适应
- 批准号:
6985329 - 财政年份:1999
- 资助金额:
$ 21.21万 - 项目类别:
PERINATAL HYPOXIA--ADRENOCORTICAL/METABOLIC ADAPTATIONS
围产期缺氧——肾上腺皮质/代谢适应
- 批准号:
6489715 - 财政年份:1999
- 资助金额:
$ 21.21万 - 项目类别:
PERINATAL HYPOXIA: ADRENOCORTICAL-METABOLIC ADAPTATIONS
围产期缺氧:肾上腺皮质代谢适应
- 批准号:
6832783 - 财政年份:1999
- 资助金额:
$ 21.21万 - 项目类别:
PERINATAL HYPOXIA: ADRENOCORTICAL-METABOLIC ADAPTATIONS
围产期缺氧:肾上腺皮质代谢适应
- 批准号:
6691701 - 财政年份:1999
- 资助金额:
$ 21.21万 - 项目类别:
相似海外基金
PET ligand discovery for arginine vasopressin
精氨酸加压素的 PET 配体发现
- 批准号:
10641669 - 财政年份:2022
- 资助金额:
$ 21.21万 - 项目类别:
PET ligand discovery for arginine vasopressin
精氨酸加压素的 PET 配体发现
- 批准号:
10356395 - 财政年份:2022
- 资助金额:
$ 21.21万 - 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
- 批准号:
10671052 - 财政年份:2021
- 资助金额:
$ 21.21万 - 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
- 批准号:
10470346 - 财政年份:2021
- 资助金额:
$ 21.21万 - 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
- 批准号:
10283131 - 财政年份:2021
- 资助金额:
$ 21.21万 - 项目类别:
Physiological role of arginine vasopressin released from RGCs on circadian rhythm and psychiatry function
RGC 释放的精氨酸加压素对昼夜节律和精神功能的生理作用
- 批准号:
19K06939 - 财政年份:2019
- 资助金额:
$ 21.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of mechanisms of arginine vasopressin receptor 1A in peripheral neuropathic pain
精氨酸加压素受体 1A 在周围神经病理性疼痛中的作用机制的鉴定
- 批准号:
18K16609 - 财政年份:2018
- 资助金额:
$ 21.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Functional mapping of arginine vasopressin receptor 1A circuits that promote anorexic behavior
促进厌食行为的精氨酸加压素受体 1A 电路的功能图谱
- 批准号:
10321547 - 财政年份:2018
- 资助金额:
$ 21.21万 - 项目类别:
Usefulness of arginine vasopressin levels on admission in risk stratification of acute decompensated heart failure with preserved left ventricular ejection fraction
入院时精氨酸加压素水平在左心室射血分数保留的急性失代偿性心力衰竭风险分层中的作用
- 批准号:
16K09448 - 财政年份:2016
- 资助金额:
$ 21.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Variation in the arginine vasopressin 1a receptor (AVPR1a) gene, the social environment, general health and wellbeing
精氨酸加压素 1a 受体 (AVPR1a) 基因的变异、社会环境、总体健康和福祉
- 批准号:
DP130100612 - 财政年份:2013
- 资助金额:
$ 21.21万 - 项目类别:
Discovery Projects














{{item.name}}会员




